Emotional energy substance and preparation method thereof
By mixing GABA, theanine, L-tyrosine, taurine, and PQQ in a specific ratio and coating them with a membrane-controlled sustained-release formulation, a mood-enhancing agent was prepared. This agent addresses the problem of rapidly improving negative emotions and enhances overall health, particularly by increasing 5-HT and NE levels, thereby alleviating insomnia and depressive symptoms.
Patent Information
- Application Number
- CN202411899444.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-23
- Publication Date
- 2026-06-23
Smart Images

Figure BDA0005202753750000041 
Figure BDA0005202753750000051 
Figure BDA0005202753750000052
Abstract
Description
Technical Field
[0001] This invention relates to the field of mood improvement technology, and in particular to a mood energy element and its preparation method. Background Technology
[0002] With increasing work pressure and insomnia, negative emotions such as depression are surging, posing significant health risks. These risks include arrhythmia and heart attacks, weakened immunity, increased inflammation, gastrointestinal disorders, and gut microbiota imbalance. Therefore, there is an urgent need to develop a mood balancer that can rapidly improve negative emotions and thus enhance overall health. Summary of the Invention
[0003] The technical problem to be solved by this invention is: there is an urgent need to develop an emotional energy element that can quickly improve negative emotions, thereby improving people's health.
[0004] To solve the above-mentioned technical problems, the technical solution adopted by the present invention is as follows:
[0005] A method for preparing an emotional energy product includes the following steps: mixing GABA, theanine, L-tyrosine, taurine, and PQQ in a mass ratio of 120-130:80-90:90-110:3.5-4.5:6.5-7.5, adding the mixture to a mixing tank, stirring and mixing evenly to obtain the emotional energy product.
[0006] Furthermore, in the above-mentioned method for preparing emotional energy, the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 125:85:100:4:7.
[0007] Furthermore, in the above-mentioned method for preparing emotional energy, after the raw materials are stirred and mixed evenly, the evenly mixed raw materials are further processed into a sustained-release formulation.
[0008] Furthermore, in the above-mentioned method for preparing emotional energy, the sustained-release formulation is based on a membrane-controlled sustained-release formulation, which is selected from microporous membrane-coated tablets or enteric-coated membrane controlled-release tablets.
[0009] The present invention also relates to emotional energy products prepared by the above-mentioned method for preparing emotional energy.
[0010] The beneficial effects of this invention are as follows: This invention develops a formula for mood energy essence, which mixes GABA, theanine, L-tyrosine, taurine, and PQQ in a specific ratio to create a composition that can relieve stress, improve negative emotions, and thus improve people's health. Detailed Implementation
[0011] To explain in detail the technical content, objectives, and effects of the present invention, the following description is provided in conjunction with the embodiments.
[0012] This invention relates to a mood balancer and its preparation method, comprising the following steps:
[0013] GABA, theanine, L-tyrosine, taurine, and PQQ are mixed in a mass ratio of 120-130:80-90:90-110:3.5-4.5:6.5-7.5, added to a mixing tank, and stirred until homogeneous to obtain the mood energy product.
[0014] Preferably, the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 125:85:100:4:7.
[0015] Preferably, after the raw materials are stirred and mixed evenly, the mixture further includes preparing a sustained-release formulation of the evenly mixed raw materials.
[0016] Preferably, the sustained-release formulation is based on a membrane-controlled sustained-release formulation, which is selected from microporous membrane-coated tablets or enteric membrane controlled-release tablets.
[0017] Microporous membrane-coated tablets: These are ordinary tablets coated with a microporous membrane. Drug molecules can diffuse out through the micropores. The coating material is usually a polymer with a certain degree of permeability, such as cellulose acetate. By controlling factors such as membrane thickness, micropore size, and number, the drug release rate can be adjusted.
[0018] Enteric-coated controlled-release tablets: These are primarily used to prevent drug degradation or irritation of the gastric mucosa in the stomach. These tablets do not release the drug in the stomach; instead, the enteric coating dissolves upon entering the alkaline environment of the small intestine, allowing for drug release. This reduces the stomach irritation caused by aspirin while achieving a slow drug release.
[0019] Example 1
[0020] An emotional energy element and its preparation method, comprising the following steps:
[0021] GABA, theanine, L-tyrosine, taurine, and PQQ were mixed in a mass ratio of 125:85:100:4:7, added to a mixing tank, and stirred until homogeneous to obtain the mood energy product.
[0022] Comparative Example 1
[0023] The difference between the emotional energy element and its preparation method described in Example 1 is that the addition of GABA is omitted.
[0024] Comparative Example 2
[0025] The difference between the emotional energy substance and its preparation method described in Example 1 is that the addition of theanine is omitted.
[0026] Comparative Example 3
[0027] The difference between the emotional energy substance and its preparation method described in Example 1 is that the addition of L-tyrosine is omitted.
[0028] Comparative Example 4
[0029] The difference between the emotional energy element and its preparation method described in Example 1 is that the addition of taurine is omitted.
[0030] Comparative Example 5
[0031] The difference between the emotional energy element and its preparation method described in Example 1 is that the addition of PPQ is omitted.
[0032] Comparative Example 6
[0033] The difference between the emotional energy element and its preparation method described in Example 1 is that the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 200:85:100:4:7.
[0034] Comparative Example 7
[0035] The difference between the emotional energy element and its preparation method described in Example 1 is that the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 200:85:100:4:0.5.
[0036] Comparative Example 8
[0037] The difference between the emotional energy element and its preparation method described in Example 1 is that the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 200:85:100:4:20.
[0038] Comparative Example 9
[0039] The difference between the emotional energy element and its preparation method described in Example 1 is that the mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 50:85:150:2:4.
[0040] Experimental Example
[0041] One hundred and ten germ-free, healthy male SD rats, weighing 200±20g, were selected and acclimatized for seven days. During the experiment, the animals had free access to food and water. The room temperature was 25±3℃, the relative humidity was 60%-70%, and the light cycle was a 12-hour day-night cycle.
[0042] A sleep deprivation chamber was prepared by means of a plastic board, which has four cylindrical platforms with a diameter of 6.5 cm and a height of 8 cm fixed to the bottom of the chamber. The longitudinal distance between each platform is 8 cm and the lateral distance is 12 cm. The water level inside the chamber is 1 cm below the level of the platforms.
[0043] A sleep deprivation rat model was established. Sufficient food and water were provided in the sleep deprivation chamber, which was kept irradiated with a 40W fluorescent lamp. The water temperature was maintained at 23-25℃. The water in the chamber was kept clean daily. The rats could move freely on the platform, eating and drinking. When they entered REM sleep, their noses would touch the water due to muscle relaxation, sometimes even falling into the water and waking them up. Because of their fear of water, the rats would climb back onto the platform, and this cycle repeated to maintain their wakefulness. During the acclimatization period, except for the control group, all other groups of rats underwent 7 days of standing training in the water deprivation chamber, 1 hour / day. Modeling began on day 8, with rats placed in the sleep deprivation chamber for 21 days of sleep deprivation, 12 hours / day (6:50 AM to 6:50 PM).
[0044] After the modeling process, the rats lost weight, their fur became dull, they became more alert and responsive to environmental stimuli, and they were easily agitated and aggressive.
[0045] A sleep deprivation rat model was established in 110 rats. They were then randomly divided into 11 groups of 10 rats each according to their body weight using a random number table. One group was the control group, which was administered physiological saline by gavage. The other 10 groups were the experimental groups, which were administered the drugs prepared in Example 1 and Comparative Examples 1-9 by gavage. The drug powder was suspended in 10 mL of water to prepare a drug suspension.
[0046] The gavage dosage for both the control group and the experimental group was 10 mL / kg / day.
[0047] Open field test:
[0048] Eight days after gavage experiments, 11 groups of rats underwent an open field test. The rats were placed in the central square of an open field box (100cm long, 100cm wide, and 40cm high). The number of times a rat horizontally crossed a square within 5 minutes was recorded as the horizontal movement score (1 point for all four paws entering a square), and the number of times the rat stood upright on its hind limbs was recorded as the vertical movement score (1 point for both front paws leaving the air or climbing a wall). The open field test score was the sum of these two scores. After each rat's test, the open field box was wiped with 75% ethanol and allowed to air dry completely before continuing the test to avoid the odor affecting the results. The average score for each group of rats was recorded.
[0049] Table 1 shows the open field test results for each group.
[0050] Table 1
[0051]
[0052]
[0053] As shown in Table 1, the rats that took the mood energy product prepared in Example 1 had the highest average total score in the open field test. The open field test reflects the rats' exploratory desire. In the insomnia model, the rats' exploratory desire decreased, leading to negative emotions such as depression, which in turn resulted in a decrease in the activity score of the open field test. Therefore, an increase in the open field test score is an important indicator of the rats' improved mood.
[0054] Sucrose water preference test:
[0055] Eight days after gavage experiments on 11 groups of rats, a sucrose water preference test was conducted. Before the test, all rats were fasted and deprived of water for 24 hours. Then, they were simultaneously given equal amounts of 1% sucrose water and pure water, which they could freely consume. After 30 minutes, the positions of the sucrose water and pure water were switched. After 60 minutes, both bottles of water were removed, and the water consumption of the rats was calculated. The sucrose water preference rate was calculated as (sucrose water consumption / total fluid consumption) × 100%.
[0056] The experimental results are shown in Table 2:
[0057] Table 2
[0058]
[0059]
[0060] As shown in Table 2, the rats that took the mood energy product prepared in Example 1 had the highest average sucrose preference rate. The sucrose preference rate reflects the rats' loss of pleasure and lack of preference for sucrose during insomnia, leading to depressive moods. Therefore, improvement in the sucrose preference rate is an important indicator for evaluating mood improvement in rats.
[0061] Serum 5-HT and NE level detection:
[0062] Eight days after gavage experiments on 11 groups of rats, serum 5-HT and NE levels were measured. The rats were anesthetized the following morning, and blood was collected from the abdominal aorta at a rate of 5 mL per rat. The vacuum blood collection tubes were placed vertically and allowed to stand for 2 hours before centrifuging for 15 minutes at 4℃, 2000 rpm, and a centrifugation radius of 15 cm. After centrifugation, the serum was stored at -80℃, and the levels of 5-HT and NE in the serum were detected using ELISA.
[0063] The experimental results are shown in Table 3:
[0064] Table 3
[0065]
[0066]
[0067] As shown in Table 3, the rats that took the emotional energy product prepared in Example 1 had the highest average serum 5-HT and NE levels. Serum 5-HT and NE levels play an important role in sleep and mood regulation. 5-HT is an important neurotransmitter in the brain, and its decrease is associated with insomnia and depression. Clinical studies have found that 5-HT reuptake inhibitors can improve sleep quality in insomnia patients, promote REM sleep and slow-wave sleep, and reduce the severity of sleep disorders. Decreased 5-HT levels limit neuronal impulse transmission, reduce brain excitability, and lead to depression. NE can regulate the excitability of the cerebral cortex, and its level is positively correlated with the production of REM sleep, affecting alertness, mood, and sensation. Decreased NE levels are closely related to the occurrence of insomnia and depression. Therefore, increasing 5-HT and NE levels has an ameliorative effect on insomnia and depression.
[0068] The above description is merely an embodiment of the present invention and does not limit the patent scope of the present invention. Any equivalent modifications made based on the content of the present invention specification, or direct or indirect applications in related technical fields, are similarly included within the patent protection scope of the present invention.
Claims
1. A method for preparing an emotional energy element, characterized in that, The process includes the following steps: GABA, theanine, L-tyrosine, taurine, and PQQ are mixed in a mass ratio of 120-130:80-90:90-110:3.5-4.5:6.5-7.5, and then added to a mixing tank and stirred until homogeneous to obtain the mood energy product.
2. The method for preparing emotional energy element according to claim 1, characterized in that, The mass ratio of GABA, theanine, L-tyrosine, taurine, and PQQ is 125:85:100:4:
7.
3. The method for preparing emotional energy element according to claim 1, characterized in that, After all the raw materials are mixed evenly, the process also includes preparing a sustained-release formulation from the evenly mixed raw materials.
4. The method for preparing emotional energy element according to claim 1, characterized in that, The sustained-release formulation is based on a membrane-controlled sustained-release formulation, which is selected from microporous membrane-coated tablets or enteric membrane controlled-release tablets.
5. An emotional energy product prepared by the method of any one of claims 1 to 4.
